Invizyne is a company specializing in Cell-Free Biomanufacturing, utilizing synthetic biological and biochemical systems to produce commercially important molecules and chemicals. Their innovative approach, SimplePath, removes cells to streamline synthetic biology, enabling the creation of simple, efficient reactors for chemical production. Invizyne's technology has been scientifically validated and patented, allowing for fast optimization, reliable scaling of production, and simplified product purification. They focus on producing high-value target molecules in markets such as cannabinoids, biofuels, and terpenes, offering solutions for natural ingredients, pharmaceuticals, and chemicals through their Enzyme-Based Biomanufacturing Systems.